InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by GOLDSMITH MARK A, Executive. Director active across 2 companies, notably Revolution Medicines, Inc.. In total, 36 filings have been published. Breakdown: 0 buy · 16 sells. Total volume traded: €2.9m. Activity tracked since 17 June 2021. The latest transaction was disclosed on 17 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations36 total
10,020 sharesCommon StockSEC:0001610717-26-000246:0
11,738 shares@ US$39.040312.6% of flowCommon StockSEC:0001610717-25-000080:0
97,400 shares0Common StockSEC:0001610717-25-000050:0
30,846 shares@ US$0.490.4% of flowCommon StockSEC:0001610717-24-000548:0
11,714 shares@ US$45.403815.1% of flowCommon StockSEC:0001610717-24-000546:0
9,100 shares@ US$4.091.0% of flowCommon StockSEC:0001610717-24-000517:0
30,000 shares@ US$4.093.4% of flowCommon StockSEC:0001610717-24-000508:0
10,000 shares@ US$4.091.1% of flowCommon StockSEC:0001610717-24-000501:0
11,715 shares@ US$44.185313.9% of flowCommon StockSEC:0001610717-24-000488:0
10,000 shares@ US$4.091.1% of flowCommon StockSEC:0001610717-24-000411:0
25,000 shares@ US$4.092.8% of flowCommon StockSEC:0001610717-24-000396:0
11,950 shares@ US$37.386612.4% of flowCommon StockSEC:0001610717-24-000352:0
7,500 shares@ US$4.090.8% of flowCommon StockSEC:0001610717-24-000285:0
7,500 shares@ US$35.48297.4% of flowCommon StockSEC:0001610717-24-000206:0
5,788 shares@ US$31.58325.0% of flowCommon StockSEC:0001610717-24-000171:0
90,000 shares0Common StockSEC:0001610717-24-000133:0
8,165 shares@ US$25.90185.8% of flowCommon StockSEC:0001610717-23-000415:0
35,000 shares@ US$0.490.5% of flowCommon StockSEC:0001610717-23-000314:0
8,054 shares@ US$31.310541.3% of flowCommon StockSEC:0001610717-23-000294:0
17,993 shares@ US$0.540.3% of flowCommon StockSEC:0001610717-23-000261:0
104,000 shares0Common StockSEC:0001567619-23-004351:0
45,000 shares@ US$0.490.6% of flowCommon StockSEC:0001567619-23-003701:0
10,000 shares@ US$0.490.1% of flowCommon StockSEC:0001567619-22-016223:0
10,336 shares@ US$0.490.1% of flowCommon StockSEC:0001567619-22-015481:0
1,023 shares@ US$18.61416.2% of flowCommon StockSEC:0001567619-22-007324:0
25 of 36 declarations
About GOLDSMITH MARK A
Mark A. Goldsmith is involved with Revolution Medicines, Inc. and CONSTELLATION PHARMACEUTICALS INC. His role involves overseeing operations and contributing to the strategy of these companies.
